Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyneuropathies and Other Disorders of the Peripheral Nervous System”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Not applicableLooking for participantsNCT07461896
What this trial is testing

Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP

Who this might be right for
Charcot-Marie-ToothCMT1AChronic Inflammatory Demyelinating Polyneuropathy (CIDP)+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 39
Very early researchWithdrawnNCT02989129
What this trial is testing

Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients

Who this might be right for
Polyneuropathies and Other Disorders of the Peripheral Nervous SystemChemotherapy Induced Neuropathic Pain
M.D. Anderson Cancer Center
Post-approval studies (Phase 4)Study completedNCT03304457
What this trial is testing

Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia

Who this might be right for
Schizophrenia
All India Institute of Medical Sciences, Bhubaneswar 100
Testing effectiveness (Phase 2)Ended earlyNCT04572893
What this trial is testing

Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities

Who this might be right for
Primary Familial Dilated Cardiomyopathy
Bristol-Myers Squibb 41
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 720
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Looking for participantsNCT07064122
What this trial is testing

AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

Who this might be right for
Haematologic Neoplasms
AstraZeneca 72
Post-approval studies (Phase 4)Study completedNCT01251211
What this trial is testing

Botulinum Toxin in Peripheral Neuropathic Pain

Who this might be right for
Postherpetic NeuralgiaDiabetic PolyneuropathiesOther Polyneuropathies
Hospital Ambroise Paré Paris 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980872
What this trial is testing

The Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Merck Sharp & Dohme LLC 60